|

Efimosfermin Clinical Trials

1 actively recruiting trial across 1 location

Also known as: BOS-580

Pipeline

Phase 2: 1

Top Sponsors

  • GlaxoSmithKline1

Indications

  • Liver Disease1
  • Metabolic Dysfunction-Associated Steatohepatitis1
  • Non Alcoholic Fatty Liver Disease1

Chandler, Arizona1 trial

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

GSK Investigational Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.